ClinicalTrials.gg
CompletedNCT07089797Updated Oct 19, 2026

Nurse-supported Mobile App for Self-help CBT-I in Informal Cancer Caregivers

An interventional study of Nurse-Supported Mobile App for Self-Help CBT-I and Sleep hygiene education in Insomnia Chronic and Cancer Caregivers, sponsored by The University of Hong Kong. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

How we know

Updated Oct 19, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
208
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 46 studies in Sleep Initiation and Maintenance Disorders by The University of Hong Kong — 14 open to participants now, 14 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · The University of Hong Kong.

Enrollment
6th of 46
208 · median 127
Started
2025
with 3 others
No phase
45 of 46
14 open now
Registered
36th of 46
by date

Among the 46 studies in Sleep Initiation and Maintenance Disorders by The University of Hong Kong, this one is the 6th largest by enrollment, is one of 4 that started in 2025, is one of 45 with no phase, and was the 36th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

14 of the 46 studies in Sleep Initiation and Maintenance Disorders by The University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 46 studies in Sleep Initiation and Maintenance Disorders by The University of Hong Kong, or all of them as a file.
02

Study summary

This mixed-methods randomized controlled trial investigates whether a nurse-supported mobile app for self-help cognitive behavioral therapy for insomnia (CBT-I) effectively reduces insomnia severity among informal cancer caregivers, compared to sleep hygiene education.\<br>\<br>

The primary research question is:\<br> Does nurse-supported mobile app for self-help CBT-I lower insomnia severity among cancer caregivers compared to sleep hygiene education at post-intervention and 3-month follow-up?\<br>\<br>

A total of 208 participants will:\<br>

  1. Be randomly assigned to one of two groups:\<br> (i) the nurse-supported mobile app-based self-help CBT-I group, which involves a 6-week CBT-I program delivered via a WeChat mini program along with weekly nurse support sessions (up to 20 minutes each); or\<br> (ii) the sleep hygiene education group.\<br>
  2. Complete assessments at baseline, post-intervention, and 3-month follow-up to measure changes in insomnia severity (primary outcome). Secondary outcomes include subjective sleep outcomes, psychological well-being, caregiver burden, fatigue, health-related quality of life, and participants' acceptability and satisfaction.\<br>\<br>

As recommended for trials of complex interventions, investigators will conduct a process evaluation in alignment with the Medical Research Council (MRC) guidance. The key functions of the process evaluation include: *(1) implementation, (2) mechanisms of impact, and (3) context.*

03

Conditions studied

  • Insomnia Chronic
  • Cancer Caregivers
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years
  • Informal caregiver (e.g., family member or a friend) who co-resides with a cancer survivor of any site or stage and provides at least 4 hours of unpaid daily care. If two or more caregivers are available for a cancer survivor, the one providing most of the daily care will be included.
  • Able to understand the research procedures, and read and communicate in Chinese
  • Able to use WeChat
  • Insomnia severity index scores > 7

Exclusion criteria

Exclusion Criteria:

  • Another sleep disorder (e.g., obstructive sleep apnea, restless leg syndrome, rapid eye movement behavior disorder), besides insomnia, that is not adequately treated
  • Psychotic disorders (e.g., bipolar disorder, schizophrenia); Suicidal ideation with intent and plan OR attempted suicide within the past 2 months
  • Currently taking any psychotropic drugs (e.g., antidepressants, anxiolytics, sleep medications)
  • Unstable or acute medical condition or condition requiring surgery in the next 6 months; Pregnancy; or Epilepsy
  • Currently participating in any other interventional program
  • Prior experience with CBT-I
  • Night, evening, early morning or rotating shift work
  • Currently caring for a cancer patient receiving hospice care
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
208 participants (actual)

Study arms

  • Experimental
    Nurse-Supported Mobile App for Self-Help CBT-I in Cancer Caregivers

    Behavioral: Nurse-Supported Mobile App for Self-Help CBT-I

  • Active comparator
    Sleep hygiene education

    Behavioral: Sleep hygiene education

Interventions

  • BehavioralNurse-Supported Mobile App for Self-Help CBT-I

    The intervention consists of two components: 1) a mobile app (i.e., WeChat mini program) delivered 6-week self-help CBT-I program; and 2) Weekly nurse support session (up to 20 minutes each) across a 6 week intervention period.

  • BehavioralSleep hygiene education

    The participants in the control group will receive only sleep hygiene (one-page handout) via WeChat. Access to the CBT-I WeChat mini program will be offered to these participants after the completion of the 3-month follow-up assessment.

06

What researchers measure

Primary outcomes

  1. Insomnia severity

    Insomnia severity will be assessed by Insomnia Severity Index (ISI). The ISI is a well-validated, 7-item scale designed to assess the severity of insomnia retrospectively over the past 2 weeks. Total scores range from 0 to 28, with higher scores indicating more severe insomnia symptoms.

    Time frame: Baseline to 18 week

Secondary outcomes

  1. Sleep patterns

    Sleep patterns (i.e., total sleep time \[TST\], time in bed \[TIB\], sleep efficiency \[SE\], wake after sleep onset \[WASO\], and sleep onset latency \[SOL\]) will be assessed using the Consensus Sleep Diary (CSD). The CSD is widely used to assess subjective sleep parameters.

    Time frame: Baseline to 18 week

  2. Sleep quality

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI is a widely used, 19-item questionnaire designed to measure various aspects of sleep quality over the past month. Scores range from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline to 18 week

  3. Caregiver burden

    The caregiver burden will be evaluated by Zarit Burden Interview-12 (ZBI-12). The ZBI-12 is a widely used, 12-item shortened version of the original ZBI, designed to assess the subjective burden experienced by informal caregivers. Total scores range from 0 to 48, with higher scores indicating a greater level of caregiver burden.

    Time frame: Baseline to 18 week

  4. Depressive symptoms

    Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a widely used, 9-item questionnaire designed to screen for, diagnose, monitor, and measure the severity of depression. Each item evaluates the frequency of depressive symptoms experienced over the past two weeks. Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.

    Time frame: Baseline to 18 week

  5. Anxiety symptoms

    Anxiety symptoms will be assessed using the Generalized Anxiety Disorder-7 (GAD-7). This self-administered, 7-item questionnaire was designed as a screening tool and a severity measure for GAD. Each item asks about the frequency of anxiety symptoms over the past two weeks. Scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms.

    Time frame: Baseline to 18 week

  6. Fatigue

    Fatigue will be assessed using the Multi-Dimensional Fatigue Inventory (MFI). The MFI is a 20-item self-report questionnaire designed to measure five dimensions of fatigue (i.e., general fatigue, mental fatigue, physical fatigue, reduced activity, and reduced motivation). Total scores range from 20 to 100, with higher scores indicating greater levels of fatigue.

    Time frame: Baseline to 18 week

  7. Health-related quality of life

    Health-related quality of life will be assessed using the five-dimension five-level European Quality of Life scale (EQ-5D-5L). The EQ-5D-5L is a standardized questionnaire designed to evaluate five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The EQ-5D-5L score ranges from -0.39 to 1, with higher scores indicating better quality of life. Additionally, the EQ-5D-5L includes a Visual Analog Scale (VAS) for overall self-rated health status, with scores ranging from 0 to 100, where higher scores represent better health-related quality of life.

    Time frame: Baseline to 18 week

  8. Participants' acceptability and satisfaction

    The participants' perspectives of acceptability and satisfaction will be evaluated using eight adapted items from the Acceptability E-scale. Each item is rated on a 5-point Likert scale, with scores ranging from 1 to 5. The total score ranges from 8 to 40, with higher scores indicating greater acceptability and satisfaction with the intervention.

    Time frame: Week 6 to week 18

  9. Adverse events

    All adverse events reported by the participants will be documented.

    Time frame: Baseline to 18 week

  10. Intervention delivery

    The delivery of the intervention will be assessed via semi-structured qualitative interviews conducted with trial participants after the intervention. Intervention adherence will also be assessed by the number of sessions completed on the WeChat mini program and the number of weekly nurse support sessions attended by participants.

    Time frame: Six weeks post-randomization

  11. Intervention acceptability

    The Intervention acceptability will be assessed via semi-structured qualitative interviews conducted with trial participants after the intervention.

    Time frame: 6 weeks post-randomization

  12. Intervention fidelity

    Throughout the study, all nurse support sessions will be recorded. A random sample of 20% of the sessions will be evaluated by a psychologist for treatment fidelity using a modified version of the Yale Adherence and Competence Scale.

    Time frame: 6 weeks post-intervention

07

Study locations

1 site
  • Shanghai University Shanghai Cancer Centre
    Shanghai, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Aug 2026, 11 months.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 11 months is below that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

Primary completion moved once since we started tracking on Sep 25, 2026: Jun 2026 → Aug 2026, on Oct 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 25, 2025
First posted
Jul 28, 2025
StartActual
Aug 11, 2025
Primary completionActual
Aug 10, 2026was Jun 2026
CompletionActual
Aug 20, 2026
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 19, 2026
Primary completion
Jun 1, 2026→Aug 10, 2026 (actual)
Oct 19, 2026
Study completion
Aug 1, 2026→Aug 20, 2026 (actual)
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Recruiting→Completed
    Primary completion Jun 1, 2026→Aug 10, 2026 (now actual)
    Study completion Aug 1, 2026→Aug 20, 2026 (now actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07089797
Responsible party
Yangxi Huang (Principal Investigator, The University of Hong Kong) — Principal investigator
First posted
Jul 28, 2025
Start date
Aug 11, 2025
Primary completion
Aug 10, 2026
Completion
Aug 20, 2026
Last update
Oct 19, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion